![Shui On Leung](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shui On Leung
Chief Executive Officer at
SINOMAB BIOSCIENCE LIMITED
Net worth: 21 M $ as of 31/05/2026
Profile
Shui On Leung is the founder of Sinomab Bioscience Ltd. since 2001, holding the title of Chairman & Chief Executive Officer.
Current job includes serving as Director at Hong Kong Genome Institute.
Former jobs include Associate Director-Molecular Biology Department at Immunomedics, Inc. from 1991 to 2000, Managing Director at The Hong Kong Institute of Biotechnology Ltd. from 2000 to 2003, and Director at Novelmab Ltd. from 2011 to 2018.
Education includes a doctorate from the University of Oxford conferred in 1989, an undergraduate degree from The Chinese University of Hong Kong conferred in 1984, a graduate degree from The Chinese University of Hong Kong conferred in 1986, and an MBA from The Chinese University of Hong Kong conferred in 2006.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 15/08/2025 | 129,729,200 ( 9.36% ) | 21 M $ | 31/05/2026 |
Shui On Leung active positions
| Companies | Position | Start |
|---|---|---|
| SINOMAB BIOSCIENCE LIMITED | Chief Executive Officer | 01/01/2003 |
Hong Kong Genome Institute | Director/Board Member | - |
Former positions of Shui On Leung
| Companies | Position | End |
|---|---|---|
Novelmab Ltd. | Director/Board Member | 01/07/2018 |
The Hong Kong Institute of Biotechnology Ltd. | Chief Executive Officer | 01/08/2003 |
| IMMUNOMEDICS, INC. | Corporate Officer/Principal | 01/07/2000 |
Training of Shui On Leung
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
96
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Chinese University of Hong Kong
 The Chinese University of Hong Kong Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Hong Kong Institute of Biotechnology Ltd. | |
Sinomab Bioscience Ltd.
 Sinomab Bioscience Ltd. BiotechnologyHealth Technology Manufactures and distributes antibodies | Health Technology |
Novelmab Ltd. | |
Hong Kong Genome Institute |
- Stock Market
- Insiders
- Shui On Leung
